{"id":17829,"date":"2025-05-26T17:02:08","date_gmt":"2025-05-26T15:02:08","guid":{"rendered":"https:\/\/adragos-pharma.com\/?p=17829"},"modified":"2025-07-11T10:26:59","modified_gmt":"2025-07-11T08:26:59","slug":"entering-japan-guide-to-pharma-compliance-market-access-e-book","status":"publish","type":"post","link":"https:\/\/adragos-pharma.com\/entering-japan-guide-to-pharma-compliance-market-access-e-book\/","title":{"rendered":"Entering Japan: Guide to Pharma Compliance &amp; Market Access [E-Book]"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">This e-book, <strong>&#8220;Entering Japan: A Practical Guide to Pharmaceutical Compliance and Market Access&#8221;<\/strong>, provides a comprehensive and practical overview for pharmaceutical companies aiming to enter the Japanese market. It explains the regulatory, logistical, and compliance challenges involved and presents step-by-step guidance on navigating Japan\u2019s complex pharmaceutical environment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Key topics:<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>General Information about Japan<\/strong>: Discover what makes Japan a strategic choice. From its aging population to a world-class healthcare system driving pharmaceutical demand.<\/li>\n\n\n\n<li><strong>Requirements for the Japanese Pharmaceutical Market<\/strong>: Navigating into the Japan\u2019s Pharmaceutical Regulations: MHLW, PMDA, MAH.<\/li>\n\n\n\n<li><strong>How To Enter The Japanese Market<\/strong>: Understand what you need to do to meet the highest Japanese quality standards.<\/li>\n\n\n\n<li><strong>Case Studies<\/strong>: Real-world examples demonstrate different scenarios, such as how a European biopharmaceutical company successfully launched in Japan and how Marketing Authorization Holder (MAH) transfers are practically managed between international companies with Japanese subsidiaries.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Overall, the guide serves as a practical reference for foreign pharmaceutical companies, offering actionable strategies and best practices to ensure successful compliance and market access in Japan.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Download the e-book now to learn how we can help you and facilitate the entrance to the Japanese market<\/strong> \ud83d\udc47<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><a href=\"https:\/\/share-eu1.hsforms.com\/1dTRb-pKbSEittJk13E0gNgfxkpu\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/05\/Infographic-E-BOOK-ENTERING-JAPAN-A-PRACTICAL-Guide-to-Pharmaceutical-Compliance-and-Market-Access.png\" alt=\"\" class=\"wp-image-17831\" srcset=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/05\/Infographic-E-BOOK-ENTERING-JAPAN-A-PRACTICAL-Guide-to-Pharmaceutical-Compliance-and-Market-Access.png 1024w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/05\/Infographic-E-BOOK-ENTERING-JAPAN-A-PRACTICAL-Guide-to-Pharmaceutical-Compliance-and-Market-Access-300x225.png 300w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/05\/Infographic-E-BOOK-ENTERING-JAPAN-A-PRACTICAL-Guide-to-Pharmaceutical-Compliance-and-Market-Access-768x576.png 768w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>This e-book, &#8220;Entering Japan: A Practical Guide to Pharmaceutical Compliance and Market Access&#8221;, provides a comprehensive and practical overview for pharmaceutical companies aiming to enter the Japanese market. It explains the regulatory, logistical, and compliance challenges involved and presents step-by-step [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":9336,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[206],"tags":[251,98,252],"topics":[78],"locations":[],"experts":[],"class_list":["post-17829","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-resources","tag-appropriate-cdmo","tag-cdmo-pharma","tag-reasons-cdmo","topics-cdmo"],"_links":{"self":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/17829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/comments?post=17829"}],"version-history":[{"count":5,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/17829\/revisions"}],"predecessor-version":[{"id":20288,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/17829\/revisions\/20288"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media\/9336"}],"wp:attachment":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media?parent=17829"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/categories?post=17829"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/tags?post=17829"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/topics?post=17829"},{"taxonomy":"locations","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/locations?post=17829"},{"taxonomy":"experts","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/experts?post=17829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}